LipoCure
Liposome-based Nano Drugs
StartupLipoCure is a Jerusalem-based startup in the Health Tech & Life Sciences sector, established in 2005. Liposome-based Nano Drugs. The company has raised a total of $8M across 1 funding round, currently at the A stage. LipoCure was founded by Yechezkel Barenholz . Key investors include Integra Holdings, Yechezkel Barenholz. The company has 1-10 employees. Core technologies: Materials & Substances, Nanomaterials.
With $8M in total funding, LipoCure is a A-stage company operating in Health Tech & Life Sciences. The company follows a B2B business model. Product stage: Clinical Trial. The company holds 1 patent.
- StageA
- ProductClinical Trial
- ModelB2B
- Employees1-10
- HQJerusalem
- DistrictJerusalem District
- Last Round$8M
- Integra Holdings
- Yechezkel Barenholz
Yechezkel Barenholz CSO and Founder
1 article covered by sources including www.businesswire.com.
What does LipoCure do?
LipoCure is developing a number of therapeutics utilizing proprietary liposome-based nano drugs with novel drug-loading capabilities and drug-release mechanisms. LipoCure's proprietary platform implements an approach that allows for remote drug loading into nano-liposomes and concomitant controlled release of the drugs at the targeted site. This technology is designed to produce an enhanced permeability and retention effect, a significantly improved therapeutic effect, and reduced side effects. It can be used in conjunction with several well-established drugs used for the treatment of rheumatoid arthritis, multiple sclerosis, and cancer. LipoCure's founder is professor Yechezkel Barenholz, the co-developer of Doxil.
How much funding has LipoCure raised?
LipoCure has raised $8M in total funding across 1 rounds. The company is currently at the A stage. Key investors include Integra Holdings, Yechezkel Barenholz.
Who founded LipoCure?
LipoCure was founded in 2005 by Yechezkel Barenholz (CSO and Founder).
What sector is LipoCure in?
LipoCure operates in Health Tech & Life Sciences, Pharma & Medical Biotechnology, Drug Delivery, with core technologies in Materials & Substances, Nanomaterials. Target customers: Healthcare & Life Sciences, Life Sciences, Pharmaceuticals.
Where is LipoCure located?
LipoCure is based in Hadassah Ein Kerem Campus, Jerusalem, Israel , Jerusalem District.